What is the recommended dose of adrenaline (epinephrine) for adult cardiac arrest vs neonatal cardiac arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adrenaline Dosing in Cardiac Arrest: Adult vs Neonatal

For adult cardiac arrest, administer 1 mg IV/IO epinephrine every 3-5 minutes; for neonatal cardiac arrest, administer 0.01 mg/kg (maximum 1 mg) IV/IO every 3-5 minutes. 1, 2

Adult Cardiac Arrest Dosing

Standard-dose epinephrine (1 mg IV/IO every 3-5 minutes) is the recommended approach for adult cardiac arrest, though evidence shows improved return of spontaneous circulation (ROSC) without proven survival benefit. 1

Key Dosing Parameters

  • Standard dose: 1 mg IV/IO administered every 3-5 minutes during resuscitation 1
  • Route priority: IV/IO preferred; if access delayed, endotracheal administration at 2-2.5 mg can be considered 1
  • No maximum cumulative dose: Guidelines do not define a maximum number of doses—continue as clinically appropriate 2

High-Dose Epinephrine (NOT Recommended)

  • High-dose epinephrine (0.1-0.2 mg/kg) is NOT recommended for routine use in adult cardiac arrest 1, 2
  • Multiple large randomized trials showed no survival benefit despite improved ROSC rates 3
  • Exception: Consider high-dose only for specific toxicologic emergencies (β-blocker or calcium channel blocker overdose) or when titrated to real-time hemodynamic monitoring 1, 2

Evidence Quality

The 2015 AHA guidelines downgraded epinephrine from "reasonable" to "may be reasonable" (Class IIb) after a placebo-controlled trial showed improved ROSC but no survival to discharge benefit, though the study was underpowered 1. The α-adrenergic vasoconstrictor effects improve coronary and cerebral perfusion pressure, but β-adrenergic effects may increase myocardial oxygen demand and reduce subendocardial perfusion 1.

Neonatal/Pediatric Cardiac Arrest Dosing

For neonates and children, the weight-based dosing is 0.01 mg/kg (0.1 mL/kg of 1:10,000 concentration) IV/IO every 3-5 minutes, with a maximum single dose of 1 mg. 2

Key Dosing Parameters

  • Pediatric dose: 0.01 mg/kg IV/IO (0.1 mL/kg of 1:10,000 solution) 2
  • Maximum single dose: 1 mg (do not exceed adult dose) 2
  • Frequency: Repeat every 3-5 minutes as needed 2
  • High-dose NOT recommended: Do not use high-dose epinephrine routinely in pediatric patients 2

Practical Calculation

  • For a 3 kg neonate: 0.01 mg/kg × 3 kg = 0.03 mg = 0.3 mL of 1:10,000 solution
  • For a 10 kg infant: 0.01 mg/kg × 10 kg = 0.1 mg = 1 mL of 1:10,000 solution
  • For a 35 kg child: 0.01 mg/kg × 35 kg = 0.35 mg, but cap at 1 mg maximum

Critical Pitfalls to Avoid

Concentration Errors

  • Adult cardiac arrest uses 1:10,000 concentration (1 mg/10 mL) for IV/IO administration 1
  • Pediatric dosing also uses 1:10,000 concentration to minimize calculation errors 2
  • The 1:1,000 concentration (1 mg/mL) is reserved for IM/subcutaneous anaphylaxis, NOT cardiac arrest 4

Timing Errors

  • Do not delay epinephrine administration beyond the first 3-5 minute interval in non-shockable rhythms 1
  • In ventricular fibrillation/pulseless VT, prioritize defibrillation first, then epinephrine after initial shocks fail 1
  • Recent data suggests administration intervals <3 minutes or >5 minutes show no outcome benefit over the recommended 3-5 minute window 5

Dosing Misconceptions

  • Do not routinely use high-dose epinephrine based on older animal studies—human trials consistently show no survival benefit 1, 3
  • Do not combine vasopressin with epinephrine as routine practice—this offers no advantage over epinephrine alone 1
  • Do not exceed 1 mg maximum in pediatric patients even if weight-based calculation suggests higher dose 2

Post-ROSC Considerations

  • Recognize that β-adrenergic effects may cause harm in the post-arrest period, including increased myocardial work and arrhythmias 1
  • Avoid epinephrine in cardiac arrest from sympathomimetic drug overdose where catecholamine excess is the underlying problem 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.